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Abstract
Background: Lymphatic insufficiency might play a significant role in the pathophysiology of lipoedema. Liposuction is up
to now the best treatment. As liposuction is invasive, the technique could destruct parts of the lymphatic system and by
this aggravate the lymphatic component and/or induce lymphoedema. We investigated the function of the lymphatic
system in lipoedema patients before and after tumescent liposuction and thus whether tumescent liposuction can be
regarded as a safe treatment.
Methods: Lymphoscintigraphy was performed to quantify the lymph outflow of 117 lipoedema patients. Mean clearance
percentages of radioactive protein loaded after 1 min with respect to the total injected dose and corrected for decay of
the radiopharmaceutical in the subcutaneous lymphatics were used as functional quantitative parameters as well as the
clearance percentages and inguinal uptake 2 h post injection. The results of lymphatic function in lipoedema patients
were compared with values obtained from normal healthy volunteers. We also compared 50 lymphoscintigraphies out of
the previous 117 lipoedema patients before and six months after tumescent liposuction.
Results: In 117 lipoedema patients clearance 2 h post injection in the right and left foot was disturbed in 79.5 and 87.2%
respectively. The inguinal uptake 2 h post injection in the right and left groin was disturbed in 60.3 and 64.7% respec-
tively. In 50 lipoedema patients mean clearance and inguinal uptake after tumescent liposuction were slightly improved,
0.01 (p¼ 0.37) versus 0.02 (p¼ 0.02), respectively. This is statistically not relevant in clearance.
Conclusion: Lipoedema legs have a delayed lymph transport. Tumescent liposuction does not diminish the lymphatic
function in lipoedema patients, thus tumescent liposuction can be regarded as a safe treatment.
Keywords
Lipoedema, tumescent liposuction, lymphoscintigraphy
Introduction
Lipoedema is a chronic, incurable disease that is often
progressive and may be associated with considerable
morbidity. It was first described by Allen and Hines1
in 1940 as a disease characterized by bilateral enlarge-
ment, mainly of the legs, caused by abnormal deposi-
tions of subcutaneous fat that are often associated with
mild oedema.2 While the arms are much less affected,
the hands and feet are never involved. It occurs almost
exclusively in women. Although the abundance of syn-
onyms indicates how little is known of this syndrome,3
it is more common than most physicians realize.
Initially, patients experience discomfort, easy bruising
and tenderness of the disproportionately enlarged legs,
which may progress to severe pain and limited
mobility.
As well as physical problems, lipoedema may
be associated with psychosocial complaints.
These complaints arise because the majority has a his-
tory of dieting and exercising without any considerable
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benefit on the contours and complaints of the lower
extremities.
The fact that it is normally first noticed at puberty,
pregnancy or menopause suggests a causative hormon-
al component, and the fact that it often affects several
members of the same family suggests a genetic compo-
nent. However, the exact pathogenesis is unknown.
Diagnosis is based on patient history and physical
examination. The course of lipoedema is variable and
partly depending on the possible concomitant obesity.
In lipoedema, the anatomy of the lymphatic vessel
system has been found to be normal, as far as the large
lymph vessels are concerned. However, the increased
intercellular pressure due to expanding fat tissue
(because of disproportionate enlargement of the adipo-
cytes) may cause slight mechanical obstruction of the
small lymphatic vessels in the septa, which result in
mild lymphostasis and oedema of the subcutaneous
tissue.4,5
However, some publications suggest that a micro-
angiopathy of the lymph capillaries located in the con-
nective tissue septa between fat lobes6 causes increased
permeability due to a fragile vessel wall. Similarly, the
easy bruising might be explained by a capillary fragil-
ity. This might also explain an increased tendency to
the formation of oedema.
The increased permeability of the lymph capillaries
leads to an increased lymphatic volume that exceeds
the existing drainage capacity and results in dilatation
of the prelymphatic vasculature. The stasis of extrava-
sation of proteins causes first inflammation followed by
fibrosis, leading to pathological changes in lymphatic
capillaries typical in lipoedema. In long-standing lip-
oedema, these small alterations of the lymphatic
tissue can be visualized by indirect lymphography.
The injection depots look flame-like, unlike the usually
visualized round deposits. The ‘tongues of flame’ are
likely to represent distended pre-lymphatic spaces.7–13
Some investigators found enlarged and obliterated lym-
phatic microvessels,11 lymphatic collectors following a
tortuous course through the fatty subcutaneous
tissue8,11 and multiple microlymphatic aneurysms of
lymphatic capillaries in patients with lipoedema,12 of
which the pathophysiological role remains to be
established.
The chronic stasis of lymphoedema also ensues adi-
pocyte hypertrophy. This adds to the lymphatic load of
an already overloaded lymphatic system (vicious cycle).
The relationship between lymphatics and adipose
tissue remains controversial.
The mechanism of lipoedema might be a continuing
deterioration in which the growing adipocytes keep
slowing the lymphatic drainage, while it is still unclear
whether the primary factor is the growing adipocyte or
an intrinsic problem in the interstitial space or micro-
lymphatic pathway.
Limb lymphatic function in lipoedema patients can
be assessed using quantitative lymphoscintigraphy.8,14–
17 This is a reliable, reproducible, minimally invasive
research method for assessing/measuring lymph flow
and detecting and quantifying lymph stasis and
dysfunction.
Photoplethysmography and quantitative lympho-
scintigraphic studies showed that insufficiency may be
present, as compared with healthy controls. However,
the degree of insufficiency never reached the level of
true lymphoedema, and large lymph vessels were
normal and sufficient.6,8,14,15,18–21
Because the pathogenesis of lipoedema is not exactly
known, a curative treatment is not available. However,
the introduction of tumescent local anaesthesia in the
1980s has greatly changed the therapeutic options for
lipoedema.22
In tumescent local anaesthesia, large amounts of
fluid and low concentration of the anaestheticum (con-
taining saline, lidocaine, sodium bicarbonate and adre-
naline) are infiltrated in the subcutaneous tissues.
Tumescent liposuction is at least as effective as the con-
ventional (‘dry’) liposuction and the so-called wet lipo-
suction in removing adipose aspirates, but has the
advantage that it is significantly less likely to damage
the lymphatic vessels.4,6,23,24 However, there is not
much scientific research done on this topic.
To establish whether the lipoedema patients initially
had a dysfunction in lymph flow or whether this was
normal, we quantified the lymph flow of lipoedema
patients using lymphoscintigraphy. To investigate
whether the function of the lymphatic system has
changed after tumescent liposuction – and thus to
establish whether tumescent liposuction can be
regarded as a safe technique – we compared lympho-
scintigraphies of lipoedema patients before and after
tumescent liposuction.
Methods
Study population
One hundred and seventeen women with lipoedema of
the legs were included in our study. All participants
provided informed consent. The mean age, when the
lymphoscintigraphy in 2010 was performed, was 40.9
years (range 21.0–64.1 years). The diagnosis of lipoe-
dema of the legs was established by clinical history and
physical examination.4 We used standardized lympho-
scintigraphy to quantify the lymph flow in all lipoe-
dema patients. The lymphatic function in lipoedema
patients was compared with those obtained from
normal volunteers.1
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Normal values of clearance (disappearance from the
depot) and inguinal uptake after 2 h post injection have
previously been established through evaluation of a
series of normal healthy volunteers without leg swelling
or other clinical evidence of venous or lymphatic dis-
ease.6,25–27
Fifty lymphoscintigraphies out of the former 117
before and six months after tumescent liposuction
were compared. The mean age was 42.2 years (range
24.1–57.9 years).
Lymphoscintigraphy
Quantitative lymphoscintigraphy is an established tech-
nique for assessment of limb lymphatic function.
Briefly, this involves subcutaneous injection of 99mTc
in the first web space. A large-field-of-view gamma
camera with on-line computer facilities is positioned
with the collimator facing close to the skin surface.
Images are obtained sequentially over feet, knees and
inguinal regions at minutes post injection.
We used mean clearance percentages of radioactive
protein loaded after 1 min with respect to the total
injected dose and corrected for decay of the radiophar-
maceutical in the subcutaneous lymphatics as function-
al quantitative parameters as well as the clearance
percentages and inguinal uptake percentages 2 h post
injection.
Clearance was disturbed 2 h post injection if <30%
(abnormal <20% plus questionable 20–30%). Inguinal
uptake was disturbed 2 h post injection if <10%
(abnormal< 5% plus questionable 5–10%).
Tumescent liposuction
Tumescent liposuction in our study was performed
according to the standard treatment as described by
Klein22 and executed by an experienced professional
who has treated lipoedema patients with this treatment
over the last 15 years.
Statistics
To describe our sample we calculated the mean and
range of the age at the time the lymphoscintigraphy
was performed. We also calculated the mean clearance
and inguinal uptake on the right and left side and cat-
egorized these values as either normal (> 30% for the
clearance and> 10% for the inguinal uptake) or
abnormal.
We looked at the correspondence of these measure-
ments on the left and the right using the Pearson’s
correlation.
To evaluate the results of the tumescent liposuction,
we compared the left, right and average clearance and
inguinal uptake using a paired t-test. We looked at the
differences (before–after) and provided a 95% confi-
dence interval.
All analyses were performed using R 3.2 (R
Foundation for Statistical Computing, Vienna,
Austria). We considered results to be statistically sig-
nificant whenever their p-value was below 0.05. No
multiplicity correction was applied.
Results
Lymphoscintigraphy results of 117 lipoedema
patients
The mean age of 117 lipoedema patients at the time the
lymphoscintigraphy was performed was 40.9 years
(range 21.0–64.1 years). Clearance in the right and
left foot was disturbed (¼ abnormalþquestionable)
in 79.5 and 87.2% respectively and normal in 20.5
and 12.8% respectively compared to normal volunteers
(Table 1). The inguinal uptake after 2 h in the right and
left groin was disturbed in 60.3 and 64.7% respectively
and normal in 39.7 and 35.3% respectively compared
to normal volunteers (Table 2).
The clearance and inguinal uptake correlation coef-
ficient 2 h post injection of radioactive protein between
right and left after 2 h were both 0.39.
Lymphoscintigraphy results of 50 lipoedema patients
before and after tumescent liposuction
All lipoedema patients were female. The mean age of
the 50 lipoedema patients at which the first lympho-
scintigraphy was performed before tumescent liposuc-
tion was 42.2 years (range 24.1–57.9 years).
Mean clearance before minus after tumescent lipo-
suction of both right and left foot (or of both feet) was
slightly improved, 0.01 (p¼ 0.37). However, this was
not statistically significant.
Mean inguinal uptake before minus after tumescent
liposuction of the groin was also slightly improved,
0.02 (p¼ 0.02). This is statistically significant (Table 3).
Table 1. Clearance foot 2 h post injection.
Frequency
(in numbers)
Per cent
(in %)
Clearance right foot 2 h post injection
Disturbed (30%) 93 79.5
Normal (>30%) 24 20.5
Total 117 100
Clearance left foot 2 h post injection
Disturbed (30%) 74 87.2
Normal (>30%) 15 12.8
Total 117 100
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The clearance and inguinal uptake correlation coef-
ficient 2 h post injection of radioactive protein between
right and left after tumescent liposuction were 0.51
versus 0.47.
Discussion
Lipoedema is a very common disease and a burden for
the patient and the medical profession. Weight reduc-
tion is not of great value due to the disturbed metabo-
lism of the lipocytes at the specific regions (legs,
buttocks and arms but never the abdomen6) where lip-
oedema is present. Nevertheless, it is true that a signif-
icant part of the lipoedema patients also has obesity.
As weight and by this BMI are not realistic parameters
to determine obesity, only abdominal circumference
can diagnose the obesity factor in lipoedema patients.
A good treatment for lipoedema is therefore a combi-
nation of obtaining a normal abdominal circumference
(women< 90 cm), exercising and specific treatment for
the areas of lipoedema.
Tumescent liposuction is the only available treat-
ment for lipoedema with good and long lasting
results.28 However, this technique could theoretically
destruct the lymphatic vessels, which will lead to
lymph transport stasis and thus to lymphoedema.
Although in lipoedema stasis of lymph in the adipose
tissue septa plays a role, this is uncorrelated to the
function of the major transporting lymph vessels of
the extremities. This means that lipoedema is not a
complication with lymfoedema. This is clearly visible
in the patients because in lymphoedema the feet are
first and always swollen but in lipoedema the feet are
never touched by the pathological process. To
investigate the potential risk of lymphoedema due to
tumescent liposuction for lipoedema, we started this
protective study.
Lymphoscintigraphy, a well established objective
instrument to measure the lymph drainage of extremi-
ties, has been performed since the 1950s and is still
currently the recommended technique for the examina-
tion of lymphoedema.29–33
We examined the lymphatic outflow of a group of
117 lipoedema patients. This study showed that most of
our lipoedema patients had a delayed leg lymph trans-
port as both clearance (disappearance from the depot)
and inguinal uptake were disturbed 2 h post injection
of radioactive protein. Whether the primary factor is
the growing adipocyte or an intrinsic problem in the
interstitial space or microlymphatic pathway is still
under discussion. However, the major lymph vessels
were normal in function. This corresponds with the
observation of Stutz34 and Schmeller et al.35
Also the clearance and inguinal correlation coeffi-
cient (n¼ 117) 2 h post injection of radioactive protein
between right and left were both 0.39. This means that
there is a moderate correlation of lymphatic function in
lipoedema patients between both legs according to
Dancey and Reidy’s correlation. In conclusion this
means that lymphatic function was rather symmetrical.
We also investigated whether the function of the
lymphatic system in 50 lipoedema patients was differ-
ent after tumescent liposuction by comparing the
values of clearance and inguinal uptake 2 h post injec-
tion. This study shows clearly that tumescent liposuc-
tion did not damage the lymphatic function as both
mean clearance and mean inguinal uptake before
minus after tumescent liposuction were slightly
improved.
The clearance and inguinal uptake correlation coef-
ficient 2 h post injection of radioactive protein between
right and left after tumescent liposuction (n¼ 50) were
0.51 versus 0.47. This means a moderate correlation of
lymphatic function in both legs in lipoedema patients
according to Dancey and Reidy’s correlation. Also here
lymphatic function was rather symmetrical.
Tumescent liposuction gave minimal improvement
in the lymphatic system but this was only statistically
significant for the inguinal uptake. Most important is
that our study proved that tumescent liposuction will
not damage the lymph vessels in lipoedema patients.
Table 2. Inguinal uptake groin 2 h post injection.
Frequency
(in numbers)
Per cent
(in %)
Inguinal uptake right leg 2 h post injection
Disturbed (10%) 70 60.3
Normal (>10%) 46 39.7
Total 116 (1 missing) 100
Inguinal uptake left leg 2 h post injection
Abnormal (10%) 75 64.7
Normal (>10%) 41 35.3
Total 116 (1 missing) 100
Table 3. Mean clearance feet and inguinal uptake groin before and minus after tumescent liposuction.
Mean (before–after
liposuction)
Sig.
(two-tailed)
95% CI of the
difference: Lower
95% CI of the
difference: Upper
ClearanceFeetBefore–ClearanceFeetAfter 0.01 0.37 0.04292 0.01612
InguinalUptakeGroinBefore–InguinalUptakeGroinAfter 0.02 0.02 0.03723 0.0042
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The outflow of lymph even increased after liposuction.
Also lipoedema patients have less lymph transport
capacity than healthy volunteers but this does not
lead to lymphoedema. We definitely need a bigger
study to have our data confirmed.
Conclusion
Lymphatic insufficiency plays a significant role in the
pathophysiology of lipoedema.
Tumescent liposuction does not diminish the lym-
phatic function in lipoedema patients.
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